Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biobanking Market to Reach $24.4bn in 2017

Published: Monday, April 08, 2013
Last Updated: Monday, April 08, 2013
Bookmark and Share
Further growth expected to 2023, predicts visiongain in new report.

A new report by visiongain predicts the world market for biobanking in human medicine will generate $24.4bn in 2017. That market was worth $12.2bn in 2012 and will expand strongly from 2013 to 2023, according to Biobanking for Medicine: Technology and Market 2013-2023, published in March 2013. Visiongain is a business information provider based in London, UK.

Visiongain forecasts that, from 2013 to 2023, the overall world market for that medical sample preservation will more than double in revenues. In the biobanking industry and market, biorepositories, biotrusts and biolibraries will develop and prosper. Their networks will also expand, nationally and internationally. Main segments for revenue growth will include the human tissue and stem cell submarkets.

Jennifer Taylor, a pharmaceutical industry analyst in visiongain, said: “That market expansion will be driven by the increasing use of banked human tissues, primary cell lines and stem cells in preclinical pharmaceutical research and development. Currently, around 90% of drugs in clinical trials fail; pharmaceutical companies are looking for more-reliable preclinical models to reduce unnecessary R&D spending. Increasingly, they are looking to human tissue and stem cell models for preclinical drug development, as they provide a more-accurate representation of how drugs will act in the clinical setting.

“The development and public awareness of stem cell treatments will also drive expansion of the market. Over the coming 10 years there will be an increase in stem cell banking for future therapeutic use. The highest rates of market expansion will occur during the first half of the forecast period. Between 2017 and 2023, this rate of expansion will begin to slow as more companies become established, increasing competition and saturating the market.”

The strength of the biobanking market derives from its vital role in drug development and personalised medicine, as well as the demand for private stem cell banking. However, the market also faces challenges of standardisation and harmonisation of biobanking practices. Also, in 2013, the market is diverse and fragmented, with biological samples contained in many small biobanks around the world; researchers often face difficulties accessing a high number of high quality biospecimens. However, the establishment of biobanking networks in many countries helps to overcome these challenges, the study concludes.

That report shows revenue forecasts to 2023 at overall world market, submarket and national level. Its research, data and analyses cover activities of Tissue Solutions, Asterand, Biopta, BioServe and other providers of technologies and services for archiving medical biosamples.

In addition to forecasting the overall world market for the topic, the study predicts revenue trends for three world-level submarkets and component segments:

Human tissue samples
Stem cells and related material
Other biopreservation (including DNA, RNA and body fluids).

Visiongain’s investigation also discusses technological and commercial news, shows seven research interviews and predicts overall revenues to 2023 in leading national markets. The study analyses the US, Japan, Germany, France, the UK, Spain, Italy (EU5), Brazil, Russia, India and China (BRIC).


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Improving Regenerative Medicine
Lab-created stem cells may lack key characteristics, UCLA research finds.
Muscles on-a-Chip
This study may help explain why stem cell-based therapies have so far shown limited benefits for heart attack patients in clinical trials.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cat Stem Cell Therapy Gives Humans Hope
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives.
Bile Acid Supports Production of Blood Stem Cells
A research group at Lund University has been able to show that bile acid is transferred from the mother to the foetus via the placenta to enable the foetus to produce blood stem cells.
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Edited Stem Cells Offer Hope of Precision Therapy for Blindness
Findings raise the possibility of treating blinding eye diseases using a patient's own corrected cells as replacement tissue.
Hacking the Programs of Cancer Stem Cells
All tumor cells are the offspring of a single, aberrant cell, but they are not all alike.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!